This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-shhttp://sh.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n30https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
n28http://dbpedia.org/resource/List_of_drugs:
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12https://www.fda.gov/ohrms/dockets/ac/98/briefingbook/
n16http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
dbpedia-srhttp://sr.dbpedia.org/resource/
n27http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/
n11http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
dbpedia-arhttp://ar.dbpedia.org/resource/
owlhttp://www.w3.org/2002/07/owl#
dbpedia-ithttp://it.dbpedia.org/resource/
dbpedia-vihttp://vi.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
dbpedia-thhttp://th.dbpedia.org/resource/
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/
dbpedia-rohttp://ro.dbpedia.org/resource/

Statements

Subject Item
dbr:Quinolone_antibiotic
dbo:wikiPageWikiLink
dbr:Temafloxacin
Subject Item
dbr:List_of_antibiotics
dbo:wikiPageWikiLink
dbr:Temafloxacin
Subject Item
dbr:List_of_causes_of_hypoglycemia
dbo:wikiPageWikiLink
dbr:Temafloxacin
Subject Item
dbr:Omniflox
dbo:wikiPageWikiLink
dbr:Temafloxacin
dbo:wikiPageRedirects
dbr:Temafloxacin
Subject Item
dbr:ATC_code_J01MA05
dbo:wikiPageWikiLink
dbr:Temafloxacin
dbo:wikiPageRedirects
dbr:Temafloxacin
Subject Item
dbr:ATCvet_code_QJ01MA05
dbo:wikiPageWikiLink
dbr:Temafloxacin
dbo:wikiPageRedirects
dbr:Temafloxacin
Subject Item
dbr:Temafloxacin
rdf:type
yago:PhysicalEntity100001930 yago:CausalAgent100007347 yago:Matter100020827 dbo:ChemicalSubstance yago:WikicatFluoroquinoloneAntibiotics n16:ChemicalObject yago:Substance100020090 yago:Drug103247620 yago:Agent114778436 wikidata:Q8386 yago:Antibacterial102716205 owl:Thing yago:WikicatPiperazines yago:WikicatWithdrawnDrugs yago:Antibiotic102716866 dbo:Drug yago:Vermifuge104528630 yago:Piperazine103946814 yago:Medicine103740161
rdfs:label
Temafloxacin تيمافلوكساسين Temafloxacina
rdfs:comment
La temafloxacina è un antibiotico che appartiene alla classe dei chinoloni di terza generazione. La molecola presentava un ampio spettro d'azione nei confronti dei batteri Gram-negativi e Gram-positivi. Sviluppata e commercializzata dalla società farmaceutica Abbott Laboratories con il nome di Omniflox (negli Usa) e di Temaflox, Temadie e Temabiotic in Italia, fu ritirata per il verificarsi di gravi effetti avversi, in particolare per la cosiddetta "sindrome da temafloxacina". Temafloxacin (marketed by Abbott Laboratories as Omniflox) is a fluoroquinolone antibiotic drug which was withdrawn from sale in the United States shortly after its approval in 1992 because of serious adverse effects resulting in three deaths. It is not marketed in Europe. Temafloxacin (تسويقه من قبل مختبرات أبوت باسم Omniflox) هو فلوروكوينولون من المضادات الحيوية وكما أنه من الأدوية التي تم سحبها من البيع في الولايات المتحدة بعد وقت قصير من الموافقة عليه في عام 1992 وذلك بسبب آثاره السلبية الخطيرة التي أدت إلى ثلاث حالات وفاة.
foaf:depiction
n11:Temafloxacin.png
dcterms:subject
dbc:Withdrawn_drugs dbc:AbbVie_brands dbc:Fluoroquinolone_antibiotics dbc:1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic_acids dbc:Hepatotoxins
dbo:wikiPageID
10686602
dbo:wikiPageRevisionID
1083515257
dbo:wikiPageWikiLink
dbr:Gastrointestinal_tract dbr:Antibiotic dbr:Prostate dbr:Bone_marrow dbr:Biological_tissues dbc:Withdrawn_drugs dbr:Community-acquired_pneumonia dbc:AbbVie_brands dbr:Tonsils dbc:Fluoroquinolone_antibiotics dbc:1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic_acids dbr:Gonococcal_urethritis dbr:Prostatitis dbr:Abbott_Laboratories dbr:Bronchitis dbr:Half-life,_biological dbr:Urinary_tract dbr:United_States dbr:Quinolones dbr:Non-gonococcal_urethritis dbr:Adverse_effect dbc:Hepatotoxins dbr:Bioavailability dbr:Fluoroquinolone dbr:Central_nervous_system dbr:Allergic_reaction dbr:Hemolytic_anemia dbr:Cervicitis dbr:Food_and_Drug_Administration dbr:Biological_fluids dbr:Skin_infection dbr:Soft_tissue
dbo:wikiPageExternalLink
n12:1998-3454B1_03_WL49.pdf
owl:sameAs
yago-res:Temafloxacin dbpedia-vi:Temafloxacin dbpedia-sr:Temafloksacin freebase:m.02qm89b dbpedia-fa:تمافلوکساسین dbpedia-ro:Temafloxacină dbpedia-it:Temafloxacina dbpedia-ar:تيمافلوكساسين wikidata:Q3983082 n27:DB01405 dbpedia-sh:Temafloksacin n30:3gCvA dbpedia-th:ทีมาฟลอกซาซิน
dbp:wikiPageUsesTemplate
dbt:Drugbox dbt:Ebicite dbt:Reflist dbt:Stdinchicite dbt:Fdacite dbt:Short_description dbt:Chemspidercite dbt:Cascite dbt:QuinoloneAntiBiotics dbt:Keggcite dbt:Drugbankcite
dbo:thumbnail
n11:Temafloxacin.png?width=300
dbp:atcSuffix
MA05
dbp:atcPrefix
J01
dbp:c
21
dbp:casNumber
108319
dbp:chebi
77788
dbp:chembl
277100
dbp:chemspiderid
54143
dbp:drugbank
DB01405
dbp:f
3
dbp:h
18
dbp:iupacName
1
dbp:kegg
D02469
dbp:legalStatus
Withdrawn
dbp:n
3
dbp:o
3
dbp:pubchem
60021
dbp:routesOfAdministration
Oral
dbp:smiles
Fc1cccN\3c2ccN4CCC
dbp:stdinchi
1
dbp:stdinchikey
QKDHBVNJCZBTMR-UHFFFAOYSA-N
dbp:tradename
Omniflox
dbp:unii
1
dbp:verifiedfields
changed
dbp:verifiedrevid
416705224
dbp:watchedfields
changed
dbo:abstract
Temafloxacin (تسويقه من قبل مختبرات أبوت باسم Omniflox) هو فلوروكوينولون من المضادات الحيوية وكما أنه من الأدوية التي تم سحبها من البيع في الولايات المتحدة بعد وقت قصير من الموافقة عليه في عام 1992 وذلك بسبب آثاره السلبية الخطيرة التي أدت إلى ثلاث حالات وفاة. Temafloxacin (marketed by Abbott Laboratories as Omniflox) is a fluoroquinolone antibiotic drug which was withdrawn from sale in the United States shortly after its approval in 1992 because of serious adverse effects resulting in three deaths. It is not marketed in Europe. La temafloxacina è un antibiotico che appartiene alla classe dei chinoloni di terza generazione. La molecola presentava un ampio spettro d'azione nei confronti dei batteri Gram-negativi e Gram-positivi. Sviluppata e commercializzata dalla società farmaceutica Abbott Laboratories con il nome di Omniflox (negli Usa) e di Temaflox, Temadie e Temabiotic in Italia, fu ritirata per il verificarsi di gravi effetti avversi, in particolare per la cosiddetta "sindrome da temafloxacina".
gold:hypernym
dbr:Drug
prov:wasDerivedFrom
wikipedia-en:Temafloxacin?oldid=1083515257&ns=0
dbo:wikiPageLength
7696
dbo:alternativeName
Omniflox
dbo:casNumber
108319-06-8
dbo:chEBI
77788
dbo:chEMBL
277100
dbo:drugbank
DB01405
dbo:fdaUniiCode
1WZ12GTT67
dbo:kegg
D02469
dbo:pubchem
60021
foaf:isPrimaryTopicOf
wikipedia-en:Temafloxacin
Subject Item
dbr:ATC_code_J01
dbo:wikiPageWikiLink
dbr:Temafloxacin
Subject Item
dbr:List_of_withdrawn_drugs
dbo:wikiPageWikiLink
dbr:Temafloxacin
Subject Item
n28:_Te
dbo:wikiPageWikiLink
dbr:Temafloxacin
Subject Item
wikipedia-en:Temafloxacin
foaf:primaryTopic
dbr:Temafloxacin